GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (HKSE:06855) » Definitions » FCF Yield %

Ascentage Pharma Group International (HKSE:06855) FCF Yield % : -10.97 (As of Jun. 23, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ascentage Pharma Group International's Trailing 12-Month Free Cash Flow is HK$-856.3 Mil, and Market Cap is HK$7,803.4 Mil. Therefore, Ascentage Pharma Group International's FCF Yield % for today is -10.97%.

The historical rank and industry rank for Ascentage Pharma Group International's FCF Yield % or its related term are showing as below:

HKSE:06855' s FCF Yield % Range Over the Past 10 Years
Min: -43.77   Med: -16.49   Max: -4.26
Current: -10.97


During the past 8 years, the highest FCF Yield % of Ascentage Pharma Group International was -4.26%. The lowest was -43.77%. And the median was -16.49%.

HKSE:06855's FCF Yield % is ranked better than
56.52% of 1550 companies
in the Biotechnology industry
Industry Median: -14.395 vs HKSE:06855: -10.97

Ascentage Pharma Group International's FCF Margin % for the quarter that ended in Dec. 2023 was -478.89%.


Ascentage Pharma Group International FCF Yield % Historical Data

The historical data trend for Ascentage Pharma Group International's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascentage Pharma Group International FCF Yield % Chart

Ascentage Pharma Group International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial -9.62 -11.60 -17.20 -14.60 -10.81

Ascentage Pharma Group International Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.64 -20.04 -13.46 -14.43 -10.48

Competitive Comparison of Ascentage Pharma Group International's FCF Yield %

For the Biotechnology subindustry, Ascentage Pharma Group International's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascentage Pharma Group International's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ascentage Pharma Group International's FCF Yield % falls into.



Ascentage Pharma Group International FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ascentage Pharma Group International's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-856.343 / 7922.3781
=-10.81%

Ascentage Pharma Group International's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-415.281 * 2 / 7922.3781
=-10.48%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascentage Pharma Group International FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ascentage Pharma Group International FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascentage Pharma Group International (HKSE:06855) Business Description

Traded in Other Exchanges
Address
68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company's geographical segments include the United States and Mainland China.
Executives
Ascentage Limited
Gao Sharon Xia
Guo Edward Ming
Healthquest Pharma Limited
Li Ju-yun
Wang Shaomeng
Yang Dajun
Zhai Yifan
South Dakota Trust Company Llc 2301 Trustee
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Tian Yuan 2201 Interest of corporation controlled by you
Zhao Li 2202 Interest of your spouse
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you
Xian Jin Zhi Zao Chan Ye Tou Zi You Xian Gong Si 2101 Beneficial owner
Guo Tou Chuang Xin Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you

Ascentage Pharma Group International (HKSE:06855) Headlines

No Headlines